New Report Molecular Diagnostics Instruments & Reagents Market Forecasts to 2017 By MarketsandMarkets

Share Article

Molecular diagnostics instruments & reagents market has crossed $4 billion mark and poised to grow at a high single-digit CAGR for the coming 5 years.

MarketsandMarkets

MarketsandMarkets

Molecular diagnostics offers tremendous opportunities in personalized medicine and preventive side of health care through better screening, early diagnosis, therapy selection and therapy monitoring.

Molecular diagnostics (MDx) is a new class of diagnostic tests that identify nucleic acids or proteins to test the status of a disease. These identified nucleic acids or proteins belong to individual patient or foreign organisms that helps to determine a specific therapy, or risk of developing a specific disease or other health condition. MDx tests are the fastest growing segment within the IVD space driven by accuracy, high sensitivity, fast turnaround time, easy workflow and cost-effective testing. Owing to this, the molecular diagnostics instruments market & reagents market has crossed $4 billion mark and poised to grow at a high single-digit CAGR for the coming 5 years.

MDx involves instruments and reagents that leverage multiple technologies to identify genetic variations. The technologies utilized in molecular diagnostics include Polymerase Chain Reaction (PCR), Transcription Mediated Amplification (TMA), qPCR, Fluorescence in Situ Hybridization (FISH), capillary electrophoresis (CE), DNA sequencing, Next Generation Sequencing (NGS), microarrays and others (e.g., bDNA, hybrid capture, hybridization beads, kPCR).

MDx has various applications in infectious disease molecular testing, oncology, blood screening, genetic testing, DNA fingerprinting (e.g., paternity testing, forensic testing), microbiology, tissue typing, and food pathogen detection testing. The booming MDx areas are molecular tests for women’s health, infectious diseases, organ transplant testing, and oncology.

Molecular diagnostics offers tremendous opportunities in personalized medicine and preventive side of health care through better screening, early diagnosis, therapy selection and therapy monitoring.

Contact:
Mr. Rohan
North - Dominion Plaza,
17304 Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-6006-441
Email: sales (at) marketsandmarkets (dot) com
MarketsandMarkets Blog
http://www.marketsandmarkets.com
http://twitter.com/marketsmarkets

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Rohan
Follow us on
Visit website